Single-cell and spatial mapping of cells in gum tissue from aggressive versus chronic periodontitis
Official title: Single-cell and Spatial Transcriptomic Profiling of Gingival Tissues in Aggressive and Chronic Periodontitis: Deciphering Cellular Heterogeneity and Inflammatory Microenvironment Features
Run by Second Affiliated Hospital, Zhejiang University, School of Medicine · NCT07487272 · Data updated 2026-11-12
This project tests whether single-cell and spatial transcriptomics plus whole-genome sequencing can find cellular and genetic differences in gum tissue from people with aggressive periodontitis compared with chronic periodontitis and healthy gums.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 20 Years to 40 Years |
| Sex | All |
| Enrollment | 9 (estimated) |
| Sponsor | Second Affiliated Hospital, Zhejiang University, School of Medicine Academic / other |
| Drugs / interventions | chemotherapy |
| Locations | 1 site (Hangzhou, Zhejiang) |
| Status | Recruiting |
| Started | December 26, 2025 |
| Main results expected | December 26, 2026 |
| Study ends | December 30, 2026 |
| Registry record updated | March 23, 2026 |
| Trial ID | NCT07487272 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal participants are adults who meet the protocol's clinical groups: 20–35 year olds with Stage III/IV, Grade C aggressive periodontitis; 30–40 year olds with Stage I/II, Grade A/B chronic periodontitis; or healthy controls aged 20–40 without radiographic bone loss, and all must be scheduled for tissue collection during routine dental surgery.
✕Probably not a fit
Patients who have used antibiotics in the past three months, smoke more than 10 cigarettes per day, or are not undergoing procedures that provide tissue samples are unlikely to benefit from joining this project.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Researchers will collect gingival tissue from patients already scheduled for tooth extraction or periodontal surgery and from healthy control donors, then profile those samples with single-cell and spatial transcriptomics to map cell types, states, and their tissue locations. Peripheral blood will undergo whole-genome sequencing to search for disease-linked genetic variants associated with aggressive periodontitis. The study compares cellular composition, mesenchymal stem cell subpopulations, gene expression signatures, signaling pathways, and spatial microenvironment patterns across aggressive, chronic, and healthy tissues. Data analysis will highlight molecular markers and spatial features that distinguish aggressive periodontitis from more common chronic forms.
Why it matters
Potential benefit: If successful, the work could reveal cellular markers, pathways, and genetic risk factors that help diagnose aggressive periodontitis earlier or point to new therapeutic targets.
How similar studies have gone: Single-cell and spatial transcriptomic methods have revealed disease-specific cell states in other inflammatory conditions and small-scale periodontal studies have begun to profile gum tissue, but combining single-cell, spatial, and whole-genome sequencing for aggressive periodontitis is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: Aggressive Periodontitis Patients: 1. Aged 20-35 years 2. Radiographic evidence of at least 30% vertical bone loss at ≥2 tooth sites 3. Can be classified as Stage III/IV, Grade C periodontitis according to the 2018 new classification of periodontitis 4. With or without family history of periodontitis 5. No significant local contributing factors (e.g., calculus, occlusal trauma, etc.) Chronic Periodontitis Patients: 1. Aged 30-40 years 2. ≥3 sites with probing depth ≥5 mm 3. Can be classified as Stage I/II, Grade A/B periodontitis according to the 2018 new classification of periodontitis 4. No significant family history 5. Disease predominantly driven by local factors (dental plaque, calculus, etc.) Healthy Controls: 1. Aged 20-40 years 2. Radiographic examination shows no significant alveolar bone loss 3. Clinically cannot be diagnosed with gingivitis or periodontitis Exclusion Criteria: 1. Use of antibiotics within the past 3 months 2. Smoking \>10 cigarettes per day 3. Uncontrolled severe diabetes (HbA1c level ≥6.7%) 4. Planning pregnancy, currently pregnant, or breastfeeding 5. Alcohol or drug addiction 6. Long-term use of immunosuppressive agents 7. Infectious diseases such as hepatitis or AIDS/HIV 8. History of malignant tumor, radiotherapy, or chemotherapy within the past 5 years
Where it's running
-
2nd Affiliated Hospital, School of Medicine, Zhejiang University, China
Hangzhou, Zhejiang, China Recruiting
Study contacts
- Study coordinator: Li-li Zhou
- Email: sophiazhou04@163.com
- Phone: +86 18329193003
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Association Between Severe Periodontitis and Arterial Stiffness: The PAROCAR Study
This study tests whether adults with generalized stage 3-4 periodontitis have greater arterial stiffness than healthy adults, to see if severe gum disease links to higher cardiovascular risk.
-
Investigating B Cell Functions in Gum Disease
This study looks at how certain immune cells called B cells behave in people with gum disease to see if they play a role in causing damage to the gums.
-
Intelligent Video Laryngoscope to Help Emergency Intubations
A smart video laryngoscope with AI is tested to help doctors place tubes in critically ill adults needing emergency intubation.
-
Understanding anxiety, depression, and bipolar disorder over time in China
This study tests how anxiety, depressive, and bipolar symptoms change over three years to find patterns that help with earlier recognition and prediction in people aged 12–55.
-
Ultrasound-guided nasal bone fracture reduction
This study tests whether using ultrasound to guide nasal bone fracture reduction can improve accuracy and outcomes for people with recent nasal injuries.
-
Simplified Tranexamic Acid Regimen for Trauma with Hemorrhage
This trial tests a simplified TXA dosing approach to see if it safely helps adults with major trauma and significant bleeding.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.